{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:49:10Z","timestamp":1771026550800,"version":"3.50.1"},"reference-count":103,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1016\/j.clindermatol.2003.08.003","type":"journal-article","created":{"date-parts":[[2003,12,11]],"date-time":"2003-12-11T11:48:51Z","timestamp":1071143331000},"page":"417-425","source":"Crossref","is-referenced-by-count":63,"title":["Superficial fungal infections: an update on pityriasis versicolor, seborrheic dermatitis, tinea capitis, and onychomycosis"],"prefix":"10.1016","volume":"21","author":[{"given":"Aditya K","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer E","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karyn","family":"Nicol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2003.08.003_BIB1","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1128\/JCM.40.4.1363-1367.2002","article-title":"New yeast species, Malassezia dermatis, isolated from patients with atopic dermatitis","volume":"40","author":"Sugita","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000249397","article-title":"Genetic susceptibility in pityriasis versicolor","volume":"171","author":"Hafez","year":"1985","journal-title":"Dermatologica"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2340\/0001555564473479","article-title":"Phenotypic characterization in situ of inflammatory cells in pityriasis (tinea) versicolor","volume":"64","author":"Scheynius","year":"1984","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1365-2133.1998.02362.x","article-title":"Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast","volume":"139","author":"Parry","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2133.2001.04082.x","article-title":"Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis","volume":"144","author":"Faergemann","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00001432-200204000-00006","article-title":"Malassezia species in skin diseases","volume":"15","author":"Crespo Erchiga","year":"2002","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000246178","article-title":"Pityriasis versicolor","volume":"197","author":"Faergemann","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1016020209891","article-title":"Isolation of Malassezia globosa and M. sympodialis from patients with pityriasis versicolor in Spain","volume":"154","author":"Aspiroz","year":"2002","journal-title":"Mycopathologia"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB9","first-page":"143","article-title":"Mycology of pityriasis versicolor","volume":"9","author":"Crespo Erchiga","year":"1999","journal-title":"J Mycol Med"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/mmy.39.2.199.206","article-title":"Epidemiology of Malassezia yeasts associated with pityriasis versicolor in Ontario, Canada","volume":"39","author":"Gupta","year":"2001","journal-title":"Med Mycol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB11","doi-asserted-by":"crossref","unstructured":"Gupta AK, Batra R, Bluhm R, et al Pityriasis versicolor. Dermatol Clin 2003;21:413\u201314","DOI":"10.1016\/S0733-8635(03)00039-1"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-4362.2000.00964.x","article-title":"An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents","volume":"39","author":"Gupta","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0190-9622(89)80167-7","article-title":"Pityriasis versicolor with ketoconazole (reply to letter)","volume":"20","author":"Jones","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/09546639909055906","article-title":"Itraconazole versus ketoconazole in the treatment of tinea versicolor","volume":"10","author":"Shemer","year":"1999","journal-title":"J Dermatol Treatment"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/095466302317584421","article-title":"Fluconazole versus ketoconazole in the treatment of tinea versicolor","volume":"13","author":"Farshcian","year":"2002","journal-title":"J Dermatol Treatment"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/095466302317584430","article-title":"Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor","volume":"13","author":"K\u00f6se","year":"2002","journal-title":"J Dermatol Treatment"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB17","first-page":"601","article-title":"Fluconazole vs","volume":"38","author":"Montero\u2013Gei","year":"1999","journal-title":"itraconazole in the treatment of tinea versicolor. Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0190-9622(96)90014-6","article-title":"A double-blind, randomized, placebo-controlled evaluation of short-term treatment with oral itraconazole in patients with tinea versicolor","volume":"34","author":"Hickman","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB19","first-page":"181","article-title":"Itraconazole in the treatment of pityriasis versicolor","volume":"32","author":"Cuce","year":"1990","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB20","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1093\/clinids\/9.Supplement_1.S134","article-title":"Itraconazole in pityriasis versicolor","volume":"9","author":"Galimberti","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB21","first-page":"90","article-title":"Oral itraconazole in the treatment of pityriasis versicolor","volume":"5","author":"Massone","year":"1991","journal-title":"Micologia Dermatologica"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB22","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/clinids\/9.Supplement_1.S121","article-title":"Randomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis versicolor","volume":"9","author":"Del Palacio-Hernanz","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB23","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1093\/clinids\/9.Supplement_1.S128","article-title":"Itraconazole in pityriasis versicolor","volume":"9","author":"Estrada","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB24","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1093\/clinids\/9.Supplement_1.S131","article-title":"Pityriasis versicolor","volume":"9","author":"Morales-Doria","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2133.1986.tb05721.x","article-title":"Itraconazole therapy in pityriasis versicolor","volume":"115","author":"Del Palacio Hernanz","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB26","first-page":"41","article-title":"Itraconazole in the treatment of pityriasis versicolor","volume":"126","author":"Simoni","year":"1991","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB27","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1093\/clinids\/9.Supplement_1.S109","article-title":"Treatment of dermatophytoses and pityriasis versicolor with itraconazole","volume":"9","author":"Panconesi","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/09546630050517496","article-title":"Oral fluconazole in the treatment of pityriasis versicolor","volume":"11","author":"Shahid","year":"2000","journal-title":"J Dermatol Treatment"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB29","first-page":"938","article-title":"Fluconazole in the treatment of tinea versicolor","volume":"36","author":"Am","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archderm.138.1.69","article-title":"Efficacy of itraconazole in the prophylactic treatment of pityriasis (tinea) versicolor","volume":"138","author":"Faergemann","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CMR.15.1.21-57.2002","article-title":"Immunology of diseases associated with Malassezia species","volume":"15","author":"Ashbee","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2133.1984.tb06631.x","article-title":"The response of seborrhoeic dermatitis to ketoconazole","volume":"111","author":"Ford","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/09546630050517450","article-title":"Evaluation of the in vitro and in vivo efficacy of butenafine hydrochloride cream 1% against Malassezia furfur species and seborrheic dermatitis","volume":"11","author":"Gupta","year":"2000","journal-title":"J Dermatol Treatment"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB34","doi-asserted-by":"crossref","unstructured":"Gupta AK, Bluhm R, Cooper EA, et al. Seborrheic dermatitis. Dermatol Clin 2003;21:401\u201312","DOI":"10.1016\/S0733-8635(03)00028-7"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB35","first-page":"1","article-title":"Itraconazole","volume":"137","author":"Caputo","year":"2002","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB36","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1046\/j.1365-2133.2001.04144.x","article-title":"Evaluation of the efficacy and tolerability of oral terbinafine (Daskil\u00ae) in patients with seborrhoeic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled trial","volume":"144","author":"Scaparro","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/sder.2001.29060","article-title":"Topical tacrolimus and pimecrolimus","volume":"20","author":"Ling","year":"2001","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB38","first-page":"470","article-title":"Tinea versicolor","volume":"34","author":"Rausch","year":"1984","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2133.1995.tb08680.x","article-title":"Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo","volume":"132","author":"Peter","year":"1995","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.clindermatol.2003.08.003_BIB40","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1365-2133.2002.04744.x","article-title":"A randomized, double-blind, parallel-group duration finding study of oral terbinafine in children with tinea capitis due to Microsporum species","volume":"146","author":"Lipozencic","year":"2002","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.clindermatol.2003.08.003_BIB41","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1542\/peds.109.4.602","article-title":"Terbinafine in the treatment of Trichophyton tinea capitis","volume":"109","author":"Friedlander","year":"2002","journal-title":"Pediatr"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB42","doi-asserted-by":"crossref","unstructured":"Romero, G, Garrido, JA, Cortina, P, et al Efficacy of oral terbinafine in children with tinea capitis caused by Microsporum canis. J Eur Acad Dermatol Venereol 1998;11(Suppl 2):S236","DOI":"10.1016\/S0926-9959(98)95456-3"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3928\/0090-4481-19980301-12","article-title":"Antifungal therapy in children","volume":"27","author":"Suarez","year":"1998","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB44","first-page":"265","article-title":"Semiquantitative study of tinea capitis and the asymptomatic carrier state in inner-city school children","volume":"96","author":"Williams","year":"1995","journal-title":"Pediatr"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/02681219680000481","article-title":"Trichophyton tonsurans tinea capitis in the San Francisco Bay area","volume":"34","author":"Wilmington","year":"1996","journal-title":"J Med Vet Mycol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/02681219880000101","article-title":"Increased incidence of Trichophyton tonsurans tinea capitis in Ontario, Canada between 1985 and 1996","volume":"36","author":"Gupta","year":"1998","journal-title":"Med Mycol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/mmy.38.4.255.287","article-title":"Tinea capitis","volume":"38","author":"Gupta","year":"2000","journal-title":"Med Mycol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB48","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00006454-199902000-00029","article-title":"The evolving role of itraconazole, fluconazole, and terbinafine in the treatment of tinea capitis","volume":"18","author":"Friedlander","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.clindermatol.2003.08.003_BIB49","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1525-1470.2001.01978.x","article-title":"Therapeutic options for the treatment of tinea capitis caused by Trichophyton species","volume":"18","author":"Gupta","year":"2001","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2230.1989.tb00901.x","article-title":"In vitro activity of terbinafine","volume":"14","author":"Clayton","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB51","doi-asserted-by":"crossref","unstructured":"Gupta AK, Cooper EA, Lynde CW. The efficacy and safety of terbinafine in children. Dermatol Clin (Submitted 2003)","DOI":"10.1016\/S0733-8635(03)00029-9"},{"issue":"5","key":"10.1016\/j.clindermatol.2003.08.003_BIB52","first-page":"276","article-title":"Coffee grinders assist pediatric dosing","volume":"65","author":"Burkhart","year":"2000","journal-title":"Cutis"},{"issue":"4","key":"10.1016\/j.clindermatol.2003.08.003_BIB53","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1525-1470.2001.01953.x","article-title":"Doubled dose of oral terbinafine is required for Microsporum canis tinea capitis","volume":"18","author":"Koumantaki","year":"2001","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB54","unstructured":"Pierini, AM, Soliani, A, Hernandez, M, et al Treatment of tinea capitis due to Microsporum canis with oral terbinafine: 40 cases. Ann Dermatol Venereol 1998;125(Suppl 1):1S133"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB55","unstructured":"Friedlander, SF, Skerlev, M, Lipozencic, J, et al Relationship between terbinafine dose and complete cure rate in tinea capitis: analysis of phase II randomized trials. J Eur Acad Dermatol Venereol 2001;15(Suppl 2):221"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB56","doi-asserted-by":"crossref","unstructured":"Gupta AK, Cooper EA, Ginter G. Efficacy and safety of itraconazole in children. Dermatol Clin (Submitted 2003)","DOI":"10.1016\/S0733-8635(03)00030-5"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB57","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0190-9622(98)70078-7","article-title":"Treatment of tinea capitis with itraconazole capsule pulse therapy","volume":"39","author":"Gupta","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB58","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1525-1470.1998.1998015225.x","article-title":"Itraconazole pulse therapy for tinea capitis","volume":"15","author":"Gupta","year":"1998","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB59","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2133.1997.18141912.x","article-title":"Itraconazole pulse therapy is effective in the treatment of tinea capitis in children","volume":"137","author":"Gupta","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB60","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-2133.1998.02323.x","article-title":"Itraconazole oral solution for the treatment of tinea capitis","volume":"139","author":"Gupta","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB61","first-page":"192","article-title":"Itraconazole oral solution for the treatment of tinea capitis using the pulse regimen","volume":"64","author":"Gupta","year":"1999","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB62","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2165\/00003495-199550040-00007","article-title":"Fluconazole-An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients","volume":"50","author":"Goa","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB63","unstructured":"Canadian Pharmacists Association. Diflucan\u2122-Pfizer-Fluconazole-Antifungal Agent. In Compendium of Pharmaceuticals and Specialties (CPS) 2002, Edition 37. Toronto: Webcom Limited. 2002:502\u20135"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB64","doi-asserted-by":"crossref","unstructured":"Gupta AK, Cooper EA, Montero-Gei F. The use of fluconazole to treat superficial fungal infections in children. Dermatol Clin 2003;21:537\u201342","DOI":"10.1016\/S0733-8635(03)00033-0"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB65","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/archpedi.153.5.483","article-title":"Asymptomatic dermatophyte carriers in the households of children with tinea capitis","volume":"153","author":"Pomeranz","year":"1999","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"10.1016\/j.clindermatol.2003.08.003_BIB66","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00006454-199902000-00026","article-title":"Tinea capitis","volume":"18","author":"Frieden","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.clindermatol.2003.08.003_BIB67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00006454-199001000-00013","article-title":"Control of the carrier state of scalp dermatophytes","volume":"9","author":"Neil","year":"1990","journal-title":"Pediatr Infect Dis J"},{"issue":"9024","key":"10.1016\/j.clindermatol.2003.08.003_BIB68","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(05)64987-2","article-title":"Treatment of symptom-free carriers in management of tinea capitis","volume":"348","author":"Greer","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB69","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/archderm.124.10.1554","article-title":"Tinea capitis","volume":"124","author":"Hebert","year":"1988","journal-title":"Curr Concepts Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB70","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2133.2000.03530.x","article-title":"Guidelines for the management of tinea capitis","volume":"143","author":"Higgins","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB71","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0190-9622(96)80137-X","article-title":"Guidelines of care for superficial mycotic infections of the skin","volume":"34","author":"Drake","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB72","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00006454-199902000-00030","article-title":"Tinea capitis","volume":"18","author":"Honig","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.clindermatol.2003.08.003_BIB73","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/00002512-200016060-00002","article-title":"Onychomycosis in the elderly","volume":"16","author":"Gupta","year":"2000","journal-title":"Drugs Aging"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB74","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1365-2133.1997.tb03673.x","article-title":"A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics","volume":"136","author":"Gupta","year":"1997","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.clindermatol.2003.08.003_BIB75","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1046\/j.1365-4362.2000.00012.x","article-title":"Epidemiology and prevalence of onychomycosis in HIV-positive individuals","volume":"39","author":"Gupta","year":"2000","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.clindermatol.2003.08.003_BIB76","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1468-3083.2000.00124.x","article-title":"The epidemiology of onychomycosis","volume":"14","author":"Gupta","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB77","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1067\/mjd.2000.104794","article-title":"Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices","volume":"43","author":"Gupta","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB78","doi-asserted-by":"crossref","unstructured":"Gupta, AK, Ryder, J. How to improve cure rates for the management of onychomycosis. Dermatol Clin 2003;21:499\u2013505","DOI":"10.1016\/S0733-8635(03)00026-3"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB79","doi-asserted-by":"crossref","unstructured":"Gupta, AK, Ryder, J, Baran, R. The use of topical therapies to treat onychomycosis. Dermatol Clin 2003;21:481\u201389","DOI":"10.1016\/S0733-8635(03)00025-1"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB80","doi-asserted-by":"crossref","unstructured":"Gupta, AK, Ryder, J. The use of oral antifungal agents to treat onychomycosis. Dermatol Clin 2003;21:469\u201379","DOI":"10.1016\/S0733-8635(03)00027-5"},{"issue":"Suppl. 1","key":"10.1016\/j.clindermatol.2003.08.003_BIB81","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1439-0507.1996.tb00517.x","article-title":"Increasing frequency of onychomycosis\u2014is there a change in the spectrum of infectious agents?","volume":"39","author":"Ginter","year":"1996","journal-title":"Mycoses"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB82","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0190-9622(08)81495-8","article-title":"Antifungal agents","volume":"30","author":"Gupta","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB83","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0190-9622(94)70112-1","article-title":"Antifungal agents","volume":"30","author":"Gupta","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB84","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0190-9622(96)90120-6","article-title":"Treatment of Candida nail infection with terbinafine","volume":"35","author":"Segal","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 43","key":"10.1016\/j.clindermatol.2003.08.003_BIB85","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2133.1994.tb06088.x","article-title":"Terbinafine in onychomycosis with involvement by non-dermatophytic fungi","volume":"130","author":"Nolting","year":"1994","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.clindermatol.2003.08.003_BIB86","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200022010-00004","article-title":"A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis","volume":"22","author":"Gupta","year":"2000","journal-title":"Drug Safety"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB87","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0190-9622(98)70316-0","article-title":"Onychomycosis associated with Onychocola canadensis","volume":"39","author":"Gupta","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.clindermatol.2003.08.003_BIB88","first-page":"87","article-title":"Nondermatophyte causes of onychomycosis and superficial mycoses","volume":"7","author":"Gupta","year":"1996","journal-title":"Curr Top Med Mycol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB89","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1365-4362.1998.00360.x","article-title":"Itraconazole for the treatment of onychomycosis","volume":"37","author":"Gupta","year":"1998","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.clindermatol.2003.08.003_BIB90","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s102270000019","article-title":"Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature","volume":"5","author":"Gupta","year":"2001","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB91","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/bmj.318.7190.1031","article-title":"Double blind, randomized study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis","volume":"318","author":"Evans","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB92","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1046\/j.1365-2133.2002.04639.x","article-title":"Long-term results in patients with onychomycosis treated with terbinafine or itraconazole","volume":"146","author":"Heikkil\u00e4","year":"2002","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.clindermatol.2003.08.003_BIB93","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archderm.138.3.353","article-title":"Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis","volume":"138","author":"Sigurgeirsson","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB94","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/archderm.138.6.811","article-title":"Oral treatments for toenail onychomycosis","volume":"138","author":"Crawford","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB95","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1365-2133.2001.04378.x","article-title":"Long-term efficacy of antifungals in toenail onychomycosis","volume":"145","author":"Cribier","year":"2001","journal-title":"Br J Dermatol"},{"issue":"Suppl 56","key":"10.1016\/j.clindermatol.2003.08.003_BIB96","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2133.1999.00009.x","article-title":"Long-term outcomes in the treatment of toenail onychomycosis","volume":"141","author":"De Cuyper","year":"1999","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.clindermatol.2003.08.003_BIB97","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1365-2133.2002.04825.x","article-title":"Terbinafine in fungal infections of the nails","volume":"147","author":"Haugh","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB98","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1365-2133.2002.04606.x","article-title":"Terbinafine (Lamisil\u00ae) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus","volume":"146","author":"Farkas","year":"2002","journal-title":"Br J Dermatol"},{"issue":"Suppl 60","key":"10.1016\/j.clindermatol.2003.08.003_BIB99","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2133.2001.145s60003.x","article-title":"The future of onychomycosis therapy may involve a combination of approaches","volume":"145","author":"Hay","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB100","first-page":"1S664","article-title":"Exploring regimens to improve efficacy in the treatment of onychomycosis","volume":"129","author":"Gupta","year":"2002","journal-title":"Ann Dermatol Venereol"},{"issue":"Suppl 60","key":"10.1016\/j.clindermatol.2003.08.003_BIB101","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2133.2001.00045.x","article-title":"Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis","volume":"145","author":"Baran","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.08.003_BIB102","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1046\/j.1365-2133.2000.03545.x","article-title":"A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycosis affecting the matrix region","volume":"142","author":"Baran","year":"2000","journal-title":"Br J Dermatol"},{"issue":"Suppl 60","key":"10.1016\/j.clindermatol.2003.08.003_BIB103","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2133.2001.145s60021.x","article-title":"Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain","volume":"145","author":"Lecha","year":"2001","journal-title":"Br J Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X03000634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X03000634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T17:08:46Z","timestamp":1704992926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X03000634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":103,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["S0738081X03000634"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2003.08.003","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}